These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18820996)

  • 1. Biological and potential therapeutic roles of sirtuin deacetylases.
    Taylor DM; Maxwell MM; Luthi-Carter R; Kazantsev AG
    Cell Mol Life Sci; 2008 Dec; 65(24):4000-18. PubMed ID: 18820996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
    Neugebauer RC; Sippl W; Jung M
    Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sirtuin class of histone deacetylases: regulation and roles in lipid metabolism.
    Fiorino E; Giudici M; Ferrari A; Mitro N; Caruso D; De Fabiani E; Crestani M
    IUBMB Life; 2014 Feb; 66(2):89-99. PubMed ID: 24488813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin deacetylases in neurodegenerative diseases of aging.
    Herskovits AZ; Guarente L
    Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of NAD+ dependent histone deacetylases (sirtuins) in ageing.
    Trapp J; Jung M
    Curr Drug Targets; 2006 Nov; 7(11):1553-60. PubMed ID: 17100594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of enzymatically active recombinant class III protein deacetylases.
    North BJ; Schwer B; Ahuja N; Marshall B; Verdin E
    Methods; 2005 Aug; 36(4):338-45. PubMed ID: 16091304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.
    Van Dyke MW
    ChemMedChem; 2014 Mar; 9(3):511-22. PubMed ID: 24449617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.
    Bouras T; Fu M; Sauve AA; Wang F; Quong AA; Perkins ND; Hay RT; Gu W; Pestell RG
    J Biol Chem; 2005 Mar; 280(11):10264-76. PubMed ID: 15632193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the Sensitivity of NAD+-dependent Sirtuin Deacylation Activities to NADH.
    Madsen AS; Andersen C; Daoud M; Anderson KA; Laursen JS; Chakladar S; Huynh FK; Colaço AR; Backos DS; Fristrup P; Hirschey MD; Olsen CA
    J Biol Chem; 2016 Mar; 291(13):7128-41. PubMed ID: 26861872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity in the Sir2 family of protein deacetylases.
    Buck SW; Gallo CM; Smith JS
    J Leukoc Biol; 2004 Jun; 75(6):939-50. PubMed ID: 14742637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of sirtuins in biological tissues.
    Shoba B; Lwin ZM; Ling LS; Bay BH; Yip GW; Kumar SD
    Anat Rec (Hoboken); 2009 Apr; 292(4):536-43. PubMed ID: 19301279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins).
    Lawson M; Uciechowska U; Schemies J; Rumpf T; Jung M; Sippl W
    Biochim Biophys Acta; 2010; 1799(10-12):726-39. PubMed ID: 20601279
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Bhatt V; Tiwari AK
    Int J Neurosci; 2023 Dec; 133(10):1167-1192. PubMed ID: 35549800
    [No Abstract]   [Full Text] [Related]  

  • 16. Sirtuins in neurodegenerative diseases: a biological-chemical perspective.
    Raghavan A; Shah ZA
    Neurodegener Dis; 2012; 9(1):1-10. PubMed ID: 22041967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases.
    Khan AN; Lewis PN
    J Biol Chem; 2006 Apr; 281(17):11702-11. PubMed ID: 16520376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into intermediate steps in the Sir2 deacetylation reaction.
    Hawse WF; Hoff KG; Fatkins DG; Daines A; Zubkova OV; Schramm VL; Zheng W; Wolberger C
    Structure; 2008 Sep; 16(9):1368-77. PubMed ID: 18786399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Sir2 family of protein deacetylases.
    Blander G; Guarente L
    Annu Rev Biochem; 2004; 73():417-35. PubMed ID: 15189148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for sirtuin function: what we know and what we don't.
    Sanders BD; Jackson B; Marmorstein R
    Biochim Biophys Acta; 2010 Aug; 1804(8):1604-16. PubMed ID: 19766737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.